English | Español

China Food And Drug Administration
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Gene Johnson | Mar 24, 2017

China approves Xeljanz to treat moderate to severe rheumatoid arthritis

Trending
+ Pharmaceuticals
Patient Daily | Aug 8, 2025

PhRMA Chief Public Affairs Officer on 340B abuse: ‘Big, tax-exempt hospitals in urban areas are using a loophole to qualify as “rural”’
Patient Daily | Aug 1, 2025

Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

American Lung Association study urges schools to prioritize clean classroom air